Sarcomatoid features OR rapid TKI progression — predicts ICI-doublet benefit; non-clear-c...
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
| ID | RF-RCC-HIGH-RISK-BIOLOGY |
|---|---|
| Type | Red flag |
| Status | pending_clinical_signoff |
| Diseases | DIS-RCC |
| Sources | SRC-ESMO-RCC-2024 SRC-NCCN-KIDNEY-2025 |
Red Flag Origin
| Definition | Sarcomatoid features OR rapid TKI progression — predicts ICI-doublet benefit; non-clear-cell distinct path. |
|---|---|
| Clinical direction | intensify |
| Category | high-risk-biology |
Trigger Logic
{
"any_of": [
{
"finding": "rcc_sarcomatoid_features",
"value": true
},
{
"finding": "rcc_non_clear_cell",
"value": true
}
],
"type": "composite_clinical"
}
Notes
Sarcomatoid clear-cell uniquely benefits from ICI doublet.
Used By
No reverse references found in the YAML corpus.